LLY•benzinga•
Eli Lilly CFO Said Co Plans To Launch Diabetes And Weight Loss Drugs In New Countries Like China, India, Brazil And Mexico In 2025; Exec Says Co Expects Negotiations With Some Insurers For Coverage Of Zepbound In Sleep Apnea In The Second Half Of The Year
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 10, 2025 by benzinga